Invasive Aspergillosis

• FDA label_change · 2015-04-03
  FDA Approved: CRESEMBA — Supplemental Application (Astellas Pharma US, Inc.)

  FDA notice of a supplemental application for CRESEMBA (isavuconazonium sulfate) submitted by Astellas Pharma US, Inc., indicating a potentia…

• FDA label_change · 2006-05-19
  FDA Approved: VFEND — Supplemental Application (Roerig)

  FDA approved a supplemental application for VFEND (voriconazole) submitted by Roerig, updating the product labeling.